Themulti-modality cardiac imaging approach to the Athletés heart: An expert consensus of the European Association of Cardiovascular Imaging

European Heart Journal Cardiovascular Imaging

Volumn 16, Issue 4, 2015, Pages 353-353T

  Galderisi, Maurizio ^a   Cardim, Nuno ^b   D'Andrea, Antonello ^c   Bruder, Oliver ^d   Cosyns, Bernard ^e   Davin, Laurent ^f   Donal, Erwan ^g   Edvardsen, Thor ^h   Freitas, Antonio ⁱ   Habib, Gilbert ^j   Kitsiou, Anastasia ^k   Plein, Sven ^l   Petersen, Steffen E ^m   Popescu, Bogdan A ⁿ   Schroeder, Stephen ^o   Burgstahler, Christof ^p   Lancellotti, Patrizio ^f  

^a FEDERICO II UNIVERSITY HOSPITAL   (Italy)

^b RM Caselas   (Portugal)

^c SECOND UNIVERSITY OF NAPLES   (Italy)

^d ELISABETH KRANKENHAUS ESSEN   (Germany)

^e Centre Hospitalier interregional Edith Cavell   (Belgium)

^f UNIVERSITY OF LIÈGE   (Belgium)

^g PONTCHAILLOU UNIVERSITY HOSPITAL   (France)

^h OSLO UNIVERSITY HOSPITAL   (Norway)

ⁱ HOSPITAL FERNANDO FONSECA   (Portugal)

^j TIMONE HOSPITAL   (France)

^k SISMANOGLIO HOSPITAL   (Greece)

^l UNIVERSITY OF LEEDS   (United Kingdom)

^m QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

ⁿ CAROL DAVILA UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^o Department of Cardiology Alb Fils Kliniken Goeppingen   (Germany)

^p UNIVERSITY OF TÜBINGEN   (Germany)

more..

Author keywords

Arrhythmogenic right ventricular cardiomyopathy; Athlet s heart; Cardiac magnetic resonance; Coronary cardiac CT; Echocardiography; Hypertrophic cardiomyopathy; Idiopathic dilated cardiomyopathy; Left ventricular hypertrophy; Nuclear cardiology

Indexed keywords

GADOLINIUM; PERFORMANCE ENHANCING SUBSTANCE; CONTRAST MEDIUM; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M;

ARTICLE; ATHLETE; CARDIOVASCULAR DISEASE; CONGESTIVE CARDIOMYOPATHY; CONSENSUS DEVELOPMENT; CORONARY ARTERY DISEASE; DIFFERENTIAL DIAGNOSIS; ECHOCARDIOGRAPHY; EUROPE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE ISCHEMIA; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; MEDICAL SOCIETY; MULTIMODAL IMAGING; MYOCARDITIS; PRIORITY JOURNAL; SUDDEN CARDIAC DEATH; ADULT; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CARDIAC IMAGING; CARDIOMEGALY; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CINE MAGNETIC RESONANCE IMAGING; COMPUTER ASSISTED TOMOGRAPHY; CONSENSUS; DEATH, SUDDEN, CARDIAC; ELECTROCARDIOGRAPHY; EUROPEAN UNION; EXERCISE INDUCED CARDIOMEGALY; GATED SINGLE PHOTON EMISSION COMPUTED TOMOGRAPHY; HYPERTROPHY, LEFT VENTRICULAR; PREDICTIVE VALUE; PROCEDURES; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS ECHOCARDIOGRAPHY;

ADULT; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CARDIAC IMAGING TECHNIQUES; CARDIAC-GATED SINGLE-PHOTON EMISSION COMPUTER-ASSISTED TOMOGRAPHY; CARDIOMEGALY; CARDIOMEGALY, EXERCISE-INDUCED; CARDIOMYOPATHY, DILATED; CARDIOMYOPATHY, HYPERTROPHIC; CONSENSUS; CONTRAST MEDIA; DEATH, SUDDEN, CARDIAC; ECHOCARDIOGRAPHY, STRESS; ELECTROCARDIOGRAPHY; EUROPEAN UNION; GADOLINIUM; HUMANS; HYPERTROPHY, LEFT VENTRICULAR; MAGNETIC RESONANCE IMAGING, CINE; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; SOCIETIES, MEDICAL; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84942092137     PISSN: 20472404     EISSN: 20472412     Source Type: Journal    
DOI: 10.1093/ehjci/jeu323     Document Type: Article

References (175)

1. Pelliccia A, Culasso F, Di Paolo FM, Maron BJ. Physiologic left ventricular cavity dilatation in elite athletes. Ann Intern Med 1999;130:23-31.
2. Pelliccia A, Maron BJ, Spataro A, Proschan MA, Spirito P. The upper limit of physiologic cardiac hypertrophy in highly trained elite athletes. N Engl J Med 1991;32: 295-301.
3. Abergel E, Chatellier G, Hagege AA, Oblak A, Linhart A, DucardonnetA et al. Serial left ventricular adaptations in world-class professional cyclists: implications for disease screening and follow-up. J Am Coll Cardiol 2004;44:144-9.
4. Wolfe LA, Cunningham DA, Davis GM, Rosenfeld H. Relationship between maximal oxygen uptake and left ventricular function in exercise. J Appl Physiol Respir Environ Exerc Physiol 1978;44:44-9.
5. Morganroth J, Maron BJ, Henry WL, Epstein SE. Comparative left ventricular dimensions in trained athletes. Ann Intern Med 1975;82:521-4.
6. Sharma S, Maron BJ, Whyte G, Firoozi S, Elliott PM, McKenna WJ. Physiologic limits of left ventricular hypertrophy in elite junior athletes: relevance to differential diagnosis of athletés heart and hypertrophic cardiomyopathy. JAmColl Cardiol 2002;40: 1431-6.
7. Pluim BM, Zwiinderman AH, van der Laarse A, van derWal EE. The athletés heart. A meta-analysis of cardiac structure and function. Circulation 2000;101:336-44.
8. Gilbert CA, Nutter DO, Felner JM, Perkins JV, Heymsfield SB, Schlant RC. Echocardiographic study of cardiac dimensions and function in the endurance-trained athlete. Am J Cardiol 1977;40:528-33.
9. Caso P, D'Andrea A, Galderisi M, Liccardo B, Severino S, De Simone L et al. Pulsed Doppler tissue imaging in endurance athletes: relation between left ventricular preload and myocardial regional diastolic function. Am J Cardiol 2000;85:1131-6.
10. Scharhag J, Schneider G, Urhausen A, RochetteV, Kramann B, KindermannW. Athletés heart: right and left ventricular mass and function in male endurance athletes and untrained individuals determined by magnetic resonance imaging. J Am Coll Cardiol 2002;40:1856-63.
11. Blair SN, Kohl HW III, Paffenbarger RS Jr, Clark DG, Cooper KH, Gibbons LW. Physical fitness and all-cause mortality. A prospective study of healthy men and women. JAMA 1989;262:2395-401.
12. Teramoto M, Bungum TJ. Mortality and longevity of elite athletes. J Sci Med Sport 2010;13:410-6.
13. Marijon E, Tafflet M, Antero-Jacquemin J, El Helou N, Berthelot G, Celermajer DS et al. Mortality of French participants in the Tour de France (1947-2012). Eur Heart J 2013;34:3045-50.
14. Corrado D, Basso C, Rizzoli G, Schiavon M, Thiene G. Does sports activity enhance the risk of sudden death in adolescents and young adults? J Am Coll Cardiol 2003;42: 1959-63.
15. Maron BJ, Doerer JJ, Haas TS, Tierney DM, Mueller FO. Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006. Circulation 2009;119:1085-92.
16. Maron BJ, Haas TS, Doerer JJ, Thompson PD, Hodges JS. Comparison of U.S. and Italian experiences with sudden cardiac deaths in young competitive athletes and implications for pre-participation screening strategies. Am J Cardiol 2009;104: 276-80.
17. Maron BJ. Sudden death in young athletes. N Engl J Med 2003;349:1064-75.
18. Chandra N, Bastiaenen R, Papadakis M, Sharma S. Sudden cardiac death in young athletes: practical challenges and diagnostic dilemmas. J Am Coll Cardiol 2013;61: 1027-40.
19. Terry GC, Kyle JM, Ellis JM Jr, Cantwell J, Courson R, Medlin R. Sudden cardiac arrest in athletic medicine. J Athl Train 2001;36:205-9.
20. Deligiannis A, Björnstad H, Carre F, Heidbüchel H, Kouidi E, Panhuyzen-Goedkoop NM et al., ESC Study Group of Sports Cardiology. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes. Eur J Cardiovasc Prev Rehabil 2006;13:687-94.
21. Pluim BM, Katwinski PJ, Montgomery HE. Cardiac effects of anabolic steroids. Heart 2004;90:473-5.
22. Nottin S, Nguyen LD, Terbah M, Obert P. Cardiovascular effects of androgenic anabolic steroids in male body builders determined by tissue Doppler imaging. Am J Cardiol 2006;97:912-5.
23. Baggish AL, Weiner RB, Kanayama G, Hudson JI, Picard MH, Hutter AM Jr et al. Long-term anabolic-androgenic steroid use is associated with left ventricular dysfunction. Circ Heart Fail 2010;3:472-6.
24. Luijkx T, Velthuis BK, Backx FJ, Buckens CF, Prakken NH, Rienks R et al. Anabolic androgenic steroid use is associated with ventricular dysfunction on cardiac MRI in strength trained athletes. Int J Cardiol 2013;167:664-8.
25. D'Andrea A, Caso P, Salerno G, Scarafile R, DeCorato G, MitaC et al. Left ventricular early myocardial dysfunction after chronic misuse of anabolic androgenic steroids: a Doppler myocardial and strain imaging analysis. Br J Sports Med 2007;41: 149-55.
26. Angell PJ, Chester N, Green DJ. Anabolic steroid use and longitudinal, radial and circumferential cardiac motion. Med Sci Sports Exerc 2012;44:583-90.
27. Angell PJ, Chester N, Sculthorpe N, Whyte G, George K, Somauroo J. Performance enhancing drug abuse and cardiovascular risk in athletes: implications for the clinician. Br J Sports Med 2012;46(Suppl. I):I78-84.
28. Schwartz BG, Rezkalla S, Kloner RA. Cardiovascular effects of cocaine. Circulation 2010;122:2558-69.
29. Aquaro GD, Gabutti A, Meini M, Prontera C, Pasanisi E, PassinoC et al. Silent myocardial damage in cocaine addicts. Heart 2011;97:2056-62.
30. Steding K, Engblom H, Buhre T, Carlsson M, Mosén H, Wohlfart B et al. Relation between cardiac dimensions and peak oxygen uptake. J Cardiovasc Magnet Res 2010;12:8.
31. Spirito P, Pelliccia A, Proschan MA, Granata M, Spataro A, Bellone P et al. Morphology of the 'athletés heart' assessed by echocardiography in 947 elites athletes representing 27 sports. Am J Cardiol 1994;74:802-6.
32. Di Paolo FM, Schmied C, Zerguini YA, Junge A, Quattrini F, Culasso F et al. The athletés heart in adolescent Africans: an electrocardiographic and echocardiographic study. J Am Coll Cardiol 2012;59:1029-236.
33. Maron BJ. Structural features of the athlete heart as defined by echocardiography. J Am Coll Cardiol 1986;7:190-203.
34. Maron BJ, Pelliccia A, Spataro A, Granata M. Reduction in left ventricular wall thickness after deconditioning in highly trained Olympic athletes. Br Heart J 1993;69: 125-8.
35. Pelliccia A, Maron BJ, De Luca R, Di Paolo FM, Spataro A, Culasso F. Remodeling of left ventricular hypertrophy in elite athletes after long-term deconditioning. Circulation 2002;105:944-9.
36. Urhausen A, Albers T, KindermannW. Are the cardiac effects of anabolic steroid abuse in strength athletes reversible? Heart 2004;90:496-501.
37. Fagard R, Van Den Broeke C, Amery A. Left ventricular dynamics during exercise in elite marathon runners. J Am Coll Cardiol 1989;14:112-8.
38. D'Andrea A, Limongelli G, Caso P, Sarubbi B, Della Pietra A, Brancaccio P et al. Association between left ventricular structure and cardiac performance during effort in two morphological forms of athletés heart. Int J Cardiol 2002;86:177-84.
39. George KP, Warburton DE, Oxborough D, Scott JM, Esch BT, Williams K et al. Upper limits of physiological cardiac adaptation in ultramarathon runners. J Am Coll Cardiol 2011;57:754-5.
40. Florescu M, Stoicescu C, Magda S, Petcu I, Radu M, Palombo C et al. 'Supranormal' cardiac function in athletes related to better arterial and endothelial function. Echocardiography 2010;27:659-67.
41. Zoncu S, Pelliccia A, Mercuro G. Assessment of regional systolic and diastolic wall motion velocities in highly trained athletes by pulsed wave Doppler tissue imaging. J Am Soc Echocardiogr 2002;15:900-5.
42. Vinereanu D, Florescu N, Schulthorpe N, Tweddel AC, Stephens MR, Fraser AG. Differentiation between pathologic and physiologic left ventricular hypertrophy by tissue Doppler assessment of long-axis function in patients with hypertrophic cardiomyopathy or systemic hypertension and in athletes. Am J Cardiol 2001;88:53-8.
43. Fagard RH. Impact of different sports and training on cardiac structure and function. Cardiology Clinics 1997;15:397-412.
44. D'Andrea A, Caso P, Severino S, Galderisi M, Sarubbi B, LimongelliG et al. Effects of different training protocols on left ventricular myocardial function in competitive athletes: a Doppler tissue imaging study. Ital Heart J 2002;3:34-5.
45. Severino S, Caso P, Galderisi M, De Simone L, Petrocelli A, de DivitiisO et al. Use of pulsed Doppler Tissue Imaging to assess regional left ventricular diastolic dysfunction in hypertrophic cardiomyopathy. Am J Cardiol 1998;82:1394-8.
46. Cardim N, Gouveia Oliveira A, Longo S. Doppler tissue imaging: regional myocardial function in hypertrophic cardiomyopathy and in athletés heart. J Am Soc Echocadiogr 2003;16:223-32.
47. Galderisi M, Caso P, Severino S, Petrocelli A, De Simone L, Izzo A et al. Myocardial diastolic impairment caused by left ventricular hypertrophy involves basal septum more than other walls: analysis by pulsed Doppler tissue imaging. J Hypertens 1999; 17:685-93.
48. MatsumuraY, Elliott PM, Virdee MS, Virdee MS, Sorajja P, DoiY et al. Left ventricular diastolic function assessed using Doppler tissue imaging in patients with hypertrophic cardiomyopathy: relation to symptoms and exercise capacity. Heart 2002;87:247-51.
49. Richand V, Lafitte S, Reant P, Serri K, Lafitte M, Brette S et al. An ultrasound speckle tracking (two-dimensional strain) analysis of myocardial deformation in professional soccer players compared with healthy subjects and hypertrophic cardiomyopathy. Am J Cardiol 2007;100:128-32.
50. Nottin S, Doucende G, Schuster-Beck I, Dauzat m, Obert P. Alteration in left ventricular normal and shear strain evaluated by 2D-strain echocardiography in the athletés heart. J Physiol 2008;586:4721-33.
51. Saghir M, Areces M, Makan M. Strain rate imaging differentiates hypertensive cardiac hypertrophy from physiologic cardiac hypertrophy (athletés heart). J Am Soc Echocardiogr 2007;20:151-7.
52. D'Andrea A, Cocchia R, Riegler L, Scarafile R, Salerno G, Gravino R et al. Left ventricular myocardial velocities and deformation indexes in top-level athletes. J Am Soc Echocardiogr 2010;23:1281-8.
53. Galderisi M, Lomoriello VS, Santoro A, Esposito R, Olibet M, Raia R et al. Differences of myocardial systolic deformation and correlates of diastolic function in competitive rowers and young hypertensives: a speckle-tracking echocardiography study. J Am Soc Echocardiogr 2010;23:1190-8.
54. Richand V, Lafitte S, Reant P, Serri K, Lafitte M, Brette S et al. An ultrasound speckle tracking (two-dimensional strain) analysis of myocardial deformation in professional soccer players compared with healthy subjects and hypertrophic cardiomyopathy. Am J Cardiol 2007;100:128-32.
55. Vitarelli A, Capotosto L, Placanica G, Caranci F, Pergolini M, Zardo F et al. Comprehensive assessment of biventricular function and aortic stiffness in athletes with different forms of training by three-dimensional echocardiography and strain imaging. Eur Heart J Cardiovasc Imaging 2013;14:1010-20.
56. Pattynama PM, Lamb HJ, van der Velde EA, van derWall EE, de Roos A. Left ventricular measurements with cine and spin-echo MR imaging: a study of reproducibility with variance component analysis. Radiology 1993;187:261-8.
57. Semelka RC, Tomei E, Wagner S, Mayo J, Caputo G, O'Sullivan M et al. Interstudy reproducibility of dimensional and functional measurements between cinemagnetic resonance studies in the morphologically abnormal left ventricle. Am Heart J 1990;119:1367-73.
58. Rehr RB, Malloy CR, Filipchuk NG, Peshock RM. Left ventricular volumesmeasured by MR imaging. Radiology 1985;156:717-9.
59. Ceelen F, Hunter RJ, Boubertakh R, Sommer WH, Armbruster M, Schilling RJ et al. Effect of atrial fibrillation ablation on myocardial function: insights from cardiac magnetic resonance feature tracking analysis. Int J Cardiovasc Imaging 2013;29: 1807-17.
60. Augustine D, Lewandowski AJ, Lazdam M, Rai A, Francis J, Myerson S et al. Global and regional left ventricular myocardial deformation measures by magnetic resonance feature tracking in healthy volunteers: comparison with tagging and relevance of gender. J Cardiovasc Magn Reson 2013;15:8.
61. Kim RJ, Fieno DS, Parrish TB, Harris K, Chen EL, Simonetti O et al. Relationship of MRI delayed contrast enhancement to irreversible injury, infarct age, and contractile function. Circulation 1999;100:1992-2002.
62. Mahrholdt H, Wagner A, Judd RM, Sechtem U. Assessment of myocardial viability by cardiovascular magnetic resonance imaging. Eur Heart J 2002;23:602-19.
63. Mahrholdt H, Wagner A, Judd RM, Sechtem U, Kim RJ. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. Eur Heart J 2005;26:1461-74.
64. Moon JC, Messroghli DR, Kellman P, Piechnik SK, Robson MD, Ugander M et al. Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMRWorking Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson 2013; 15:92.
65. Petersen SE, Selvanayagam JB, Francis JM, Myerson SG, Wiesmann F, Robson MD et al. Differentiation of athletés heart from pathological forms of cardiac hypertrophy by means of geometric indices derived from cardiovascularmagnetic resonance. J Cardiovasc Magn Reson 2005;7:551-8.
66. Rickers C, Wilke NM, Jerosch-Herold M, Casey SA, Panse P, PanseN et al. Utility of cardiac magnetic resonance imaging in the diagnosis of hypertrophic cardiomyopathy. Circulation 2005;112:855-61.
67. Moon JC, Fisher NG, McKenna WJ, Pennell DJ. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with nondiagnostic echocardiography. Heart 2004;90:645-9.
68. Bruder O, Wagner A, Jensen CJ, Schneider S, Ong P, Kispert EM et al. Myocardial scar visualized by cardiovascular magnetic resonance imaging predicts major adverse events in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:875-87.
69. O'Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:867-74.
70. Petersen SE, Jerosch-Herold M, Hudsmith LE, Robson MD, Francis JM, Doll HA et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multiparametric magnetic resonance imaging. Circulation 2007; 115:2418-25.
71. Moon JC, McKenna WJ, McCrohon JA, Elliott PM, Smith GC, Pennell DJ. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003;41:1561-7.
72. McCrohon JA, Moon JC, Prasad SK, McKenna WJ, Lorenz CH, Coats AJ et al. Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation 2003;108:54-9.
73. Mangold S, Kramer U, Franzen E, Erz G, Bretschneider C, Seeger A et al. Detection of cardiovascular disease in elite athletes using cardiac magnetic resonance imaging. Rofo 2013;185:1167-74.
74. Maron BJ, Pelliccia A, Spirito P. Cardiac disease in young trained athletes. Insights into methods for distinguishing athletés heart from structural heart disease, with particular emphasis on hypertrophic cardiomyopathy. Circulation 1995;91: 1596-601.
75. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, KhanM et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1977-85.
76. Pelliccia A, Maron BJ, Di Paolo FM, Biffi A, Quattrini FM, PisicchioC et al. Prevalence and clinical significance of left atrial remodeling in competitive athletes. J Am Coll Cardiol 2005;46:690-6.
77. D'Andrea A, Riegler R, Cocchia R, Scarafile R, Salerno G, Gravino R et al. Left atrial volume index in highly trained athletes. Am Heart J 2010;159:1155-61.
78. Molina L, Mont L, Marrugat J, Berruezo A, Brugada J, Bruguera J et al. Long-term endurance sport practice increases the incidence of lone atrial fibrillation in men: a follow-up study. Europace 2008;10:618-23.
79. Mont L, Elosua R, Brugada J. Endurance sport practice as a risk factor for atrial fibrillation and atrial flutter. Europace 2009;11:11-7.
80. Mont L, Tamborero D, Elosua R, Molina I, Coll-Vinent B, Sitges M et al. GIRAFA (Grup Integrat de Recerca en Fibril-laciò Auricular) investigators. Physical activity, height, and left atrial size are independent risk factors for lone atrial fibrillation in middle-aged healthy individuals. Europace 2008;10:15-20.
81. Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA et al.; Chamber Quantification Writing Group; American Society of Echocardiography's Guidelines and Standards Committee; European Association of Echocardiography. Recommendations for chamber quantification: a report from theAmerican Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjuction with the European Association of Echocardiography, a branch of the European Society of Cardiology. Eur J Echocardiogr 2006;7:79-108.
82. Abhayaratna WP, Seward JB, Appleton CP, Douglas PS, Oh JK, Tajik AJ et al. Left atrial size: physiologic determinants and clinical applications. J Am Coll Cardiol 2006;47:2357-663.
83. Nagueh SF, Appleton CP, Gillebert TC, Marino PN, Oh JK, Smiseth OA et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009;10:165-93.
84. Thomas L, Levett K, Boyd A, Leung DY, Schiller NB, Ross DL. Compensatory changes in atrial volumes with normal aging: is atrial enlargement inevitable? J Am Coll Cardiol 2002;40:1630-5.
85. Aurigemma GP, Gottdiener JS, Arnold AM, Chinali M, Hill JC, Kitzman D. Left atrial volume and geometry in healthy aging. The Cardiovascular Health study. Circ Cardiovasc Imaging 2009;2:282-9.
86. Nistri S, Galderisi M, Ballo P, Olivotto I, D'Andrea A, Pagliani L et al., on behalf of the Working Group of Echocardiography of the Italian Society of Cardiology. Determinants of echocardiographic left atrial size: implications for normalcy. Eur J Echocardiogr 2011;12:826-33.
87. Kou S, Caballero L, Dulgheru R, Voilliot D, De Sousa C, KacharavaG et al. Echocardiographic reference ranges from normal cardiac chamber size: results from NORRE study. Eur Heart J Cardiovasc Imaging 2014;15:680-90.
88. Gati S, Sheikh N, Ghani S, Zaidi A, Wilson M, Raju H et al. Should axis deviation or atrial enlargement be categorised as abnormal in young athletes? The athletés electrocardiogram: time for re-appraisal of markers of pathology. Eur Heart J 2013;34: 3461-8.
89. D'Ascenzi F, Pelliccia A, Natali BM, Zacà V, Cameli M, Alvino F et al. Morphological and Functional adaptation of left and right atria induced by training in highly trained female athletes. Circ Cardiovasc Imag 2014;7:222-9.
90. Gabrielli L, Enríquez A, Córdova S, Yáñez F, Godoy I, Corbalán R. Assessment of left atrial function in hypertrophic cardiomyopathy and athletés heart: a left atrial myocardial deformation study. Echocardiography 2012;29:943-9.
91. Scharf M, BremMH, Wilhelm M, Schoepf UJ, Uder M, LellMM.Atrial and ventricular functional and structural adaptations of the heart in elite triathletes assessed with cardiac MR imaging. Radiology 2010;257:71-9.
92. Mosén H, Steding-Ehrenborg K. Atrial remodelling is less pronounced in female endurance-trained athletes compared with that in male athletes. Scand Cardiovasc J 2014;48:20-6.
93. Knutsen KM, Stugaard M, Michelsen S, Otterstad JE. M-mode echocardiographic findings in apparently healthy, nonathletic Norwegians aged 20-70 years. Influence of age, sex and body surface area. J Intern Med 1989;225:111-5.
94. D'Andrea A, Riegler L, Golia E, Cocchia R, Scarafile R, SalernoG et al. Range of right heart measurements in top-level athletes: the training impact. Int J Cardiol 2013;164: 48-57.
95. Hauser AM, Dressendorfer RH, Vos M, Hashimoto T, Gordon S, Timmis GC. Symmetric cardiac enlargement in highly trained endurance athletes: a two-dimensional echocardiographic study. Am Heart J 1985;109:1038-44.
96. Goldhammer E, Mesnick N, Abinader EG, Sagiv M. Dilated inferior vena cava: a common echocardiographic finding in highly trained elite athletes. JAmSoc Echocardiogr 1999;12:988-93.
97. Scharhag J, Schneider G, Urhausen A, RochetteV, Kramann B, KindermannW. Athletés heart: right and left ventricular mass and function in male endurance athletes and untrained individuals determined by magnetic resonance imaging. J Am Coll Cardiol 2002;40:1856-63.
98. Scharf M, Brem MH, Wilhelm M, Schoepf UJ, Uder M, Lell MM. Cardiac magnetic resonance assessment of left and right ventricular morphologic and functional adaptations in professional soccer players. Am Heart J 2010;159:911-8.
99. Baggish AL, Wang F, Weiner RB, Elinoff JM, Tournoux F, Boland A et al. Trainingspecific changes in cardiac structure and function: a prospective and longitudinal assessment of competitive athletes. J Appl Physiol 2008;104:1121-8.
100. UtomiV, Oxborough D, WhyteGP, SomaurooJ, Sharma S, ShaveR et al. Systematic review and meta-analysis of training mode, imaging modality and body size influences on the morphology and function of the male athletés heart. Heart 2013; 99:1727-33.
101. Rudski LG, LaiWW, Afilalo J, Hua L, HandschumacherMD, ChandrasekaranK et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J Am Soc Echocardiogr 2010;23:685-713.
102. Sen-Chowdhry S, Lowe MD, Sporton SC, McKenna WJ. Arrhythmogenic right ventricular cardiomyopathy: clinical presentation, diagnosis, and management. Am J Med 2004;117:685-95.
103. Zaidi A, Ghani S, Sheikh N, Gati S, Bastiaenen R, Madden B et al. Clinical significance of electrocardiographic right ventricular hypertrophy in athletes: comparison with arrhythmogenic right ventricular cardiomyopathy and pulmonary hypertension. Eur Heart J 2013;34:3649-56.
104. Sen-Chowdhry S, Prasad SK, McKenna WJ. Complementary role of echocardiography and cardiac magnetic resonance in the non-invasive evaluation of suspected arrhythmogenic right ventricular cardiomyopathy. J Interv Card Electrophysiol 2004; 11:15-7.
105. D'Andrea A, Riegler L, Morra S, Scarafile R, Salerno G, Cocchia R et al. Right ventricular morphology and function in top-level athletes: a three-dimensional echocardiographic study. J Am Soc Echocardiogr 2012;25:1268-76.
106. Esposito R, Galderisi M, Schiano-Lomoriello V, Santoro A, De Palma D, Ippolito R et al. Nonsymmetric myocardial contribution to supranormal right ventricular function in the athletés heart: combined assessment by Speckle Tracking and real time three-dimensional echocardiography. Echocardiography 2013;31: 996-1004.
107. Nagueh SF, Bierig SM, Budoff MJ, Desai M, Dilsizian V, Eidem B et al. American Society of Echocardiography; American Society of Nuclear Cardiology; Society for Cardiovascular Magnetic Resonance; Society of Cardiovascular Computed Tomography. American Society of Echocardiography clinical recommendations for multimodality cardiovascular imaging of patients with hypertrophic cardiomyopathy: endorsed by the American Society of Nuclear Cardiology, Society for Cardiovascular Magnetic Resonance, and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr 2011;24:473-98.
108. Nishimura RA, Ommen SR, Rakowski H, Seidman CE, Towbin JA, Udelson JE. 2011 ACCF/AHA guidelines for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/ American Heart Association Task Force on Practice Guidelines. Circulation 2011;124:2761-96.
109. Grothues F, Moon JC, Bellenger NG, Smith GS, Klein HU, Pennell DJ. Interstudy reproducibility of right ventricular volumes, function, and mass with cardiovascular magnetic resonance. Am Heart J 2004;147:218-23.
110. Maron MS. Clinical utility of cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Cardiovasc Magn Reson 2012;1:14:13.
111. Marcus FI, McKenna WJ, Sherrill D, Basso C, Bauce B, Bluemke DA et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the task force criteria. Circulation 2010;121:1533-41.
112. Luijkx T, Velthuis BK, Prakken NH, Cox MG, Bots ML, Mali WP et al. Impact of revised Task Force Criteria: distinguishing the athletés heart from ARVC/D using cardiac magnetic resonance imaging. Eur J Prev Cardiol 2012;19:885-91.
113. Kirchhof P, Fabritz L, Zwiener M, Witt H, Schäfers M, Zellerhoff S et al. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation 2006;114:1799-806.
114. James CA, Bhonsale A, Tichnell C, Murray B, Russell SD, Tandri H et al. Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriers. J Am Coll Cardiol 2013;62:1290-7.
115. Corrado D, Pelliccia A, Bjørnstad HH, Vanhees L, Biffi A, Borjesson M et al. Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiologyand theWorking Groupof Myocardial and Pericardial Diseases of the European Society of Cardiology. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol. Consensus statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and theWorking Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005;26:516-24.
116. Maron BJ, Thompson PD, Ackerman MJ, Balady G, Berger S, CohenD et al., American Heart Association Council on Nutrition, Physical Activity, and Metabolism. Recommendations and considerations related to pre-participation screening for cardiovascular abnormalities in competitive athletes: 2007 update: a scientific statement from the American Heart Association Council onNutrition, Physical Activity, and Metabolism: endorsed by the American College of Cardiology Foundation. Circulation 2007;115:1643-455.
117. Borjesson M, Urhausen A, Kouidi E, Dugmore D, Sharma S, Halle M et al. Cardiovascular evaluation of middle-aged/ senior individuals engaged in leisure-time sport activities: position stand from the sections of exercise physiology and sports cardiology of the European Association of Cardiovascular Prevention and Rehabilitation. Eur J Cardiovasc Prev Rehabil 2011;18:446-58.
118. La Gerche A, Baggish AL, Knuuti J, Prior DL, Sharma S, Heidbuchel H et al. Cardiac imaging and stress testing asymptomatic athletes to identify those at risk of sudden cardiac death. JACC Cardiovasc Imaging 2013;6:993-1007.
119. Zeppilli P, Dello Russo A, Santini C, Palmieri V, Natale L, Giordano A. In vivo detection of coronary artery anomalies in asymptomatic athletes by echocardiographic screening. Chest 1998;114:89-93.
120. Garber AM, Solomon NA. Cost-effectiveness of alternative test strategies for the diagnosis of coronary artery disease. Ann Intern Med 1999;130:719-28.
121. D'Andrea A, Severino S, Caso P, Liccardo B, Forni A, FuscoA et al. Prognostic value of supine bicycle exercise stress echocardiography in patients with known or suspected coronary artery disease. Eur J Echocardiogr 2005;6:271-9.
122. Hildick-Smith DJ, Johnson PJ, Wisbey CR, Winter EM, Shapiro LM. Coronary flow reserve is supranormal in endurance athletes: an adenosine transthoracic echocardiographic study. Heart 2000;84:383-9.
123. Bartram P, Toft J, Hanel B, Ali S, Gustafsson F, Mortensen J et al. False-positive defects in technetium-99 m sestamibi myocardial single-photon emission tomography in healthy athletes with left ventricular hypertrophy. Eur J Nucl Med 1998; 25:1308-12.
124. Andersson LG, Henriksen E, Damm S, Jonason T, Niklasson U, Wesslén L et al. Thallium-201 myocardial imaging at rest in male orienteers and other endurance athletes. Ups J Med Sci 2001;106:59-66.
125. Takala TO, Nuutila P, Katoh C, Luotolahti M, Bergman J, Mäki M et al. Myocardial blood flow, oxygen consumption, and fatty acid uptake in endurance athletes during insulin stimulation. Am J Physiol 1999;277:E585-90.
126. Takala TO, Nuutila P, Knuuti J, Luotolahti M, Yki-Jarvinen H. Insulin action on heart and skeletal muscle glucose uptake in weightlifters and endurance athletes. Am J Physiol 1999;276:E706-11.
127. MatsuoS, NakamuraY, TakahashiM, MatsuiT, Kusukawa J, Yoshida S et al.Cardiac sympathetic dysfunction in an athletés heart detected by 123I-metaiodobenzylguanidine scintigraphy. Jpn Circ J 2001;65:371-4.
128. Estorch M, Serra-Grima R, Flotats A, Marí C, Bernà L, Catafau A et al. Myocardial sympathetic innervation in the athletés sinus bradycardia: is there selective inferior myocardial wall denervation? J Nucl Cardiol 2000;7:354-8.
129. Leschka S, Koepfli P, Husmann L, Plass A, Vachenauer R, Gaemperli O et al. Myocardial bridging: depiction rate and morphology at CT coronary angiography- comparison with conventional coronary angiography. Radiology 2008;246:754-62.
130. Schroeder S, Achenbach S, Bengel F, Burgstahler C, Cademartiri F, de Feyter P. Cardiac computed tomography: indications, applications, limitations, and training requirements: report of a Writing Group deployed by the Working Group Nuclear Cardiology and Cardiac CT of the European Society of Cardiology and the European Council of Nuclear Cardiology. Eur Heart J 2008;29:531-56.
131. Möhlenkamp S, Lehmann N, Breuckmann F, Bröcker-Preuss M, Nassenstein K, Halle M et al. Running the risk of coronary events: prevalence and prognostic relevance of coronary atherosclerosis in marathon runners. Eur Heart J 2008;29: 903-1910.
132. Thiene G, Corrado D, Schiavon M, Basso C. Screening of competitive athletes to prevent sudden death: implement programmes now. Heart 2013;99:304-6.
133. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, Budaj A et al. ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J 2013;34:2949-3003.
134. Bruder O, Wagner A, Lombardi M, Schwitter J, van Rossum A, PilzG et al. European Cardiovascular Magnetic Resonance (EuroCMR) registry-multinational results from 57 centers in 15 countries. J Cardiovasc Magn Reson 2013;15:9.
135. Petersen SE, Jerosch-Herold M, Hudsmith LE, Robson MD, Francis JM, Doll HA et al. Evidence for microvascular dysfunction in hypertrophic cardiomyopathy: new insights from multi-parametric magnetic resonance imaging. Circulation 2008; 115:2418-25.
136. Karamitsos TD, Dass S, Suttie J, Sever E, Birks J, Holloway CJ et al. Blunted myocardial oxygenation response during vasodilator stress in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2013;61:1169-76.
137. Prakken NH, Cramer MJ, Olimulder MA, Agostoni P, MaliWP, Velthuis BK. Screening for proximal coronary artery anomalies with 3-dimensional MR coronary angiography. Int J Cardiovasc Imaging 2010;26:701-10.
138. Shave R, Baggish A, George K, Wood M, Scharhag J, Whyte G et al. Exercise-induced cardiac troponin elevation: evidence, mechanisms, and implications. J Am Coll Cardiol 2010;56:169-76.
139. Mousavi N, Czarnecki A, Kumar K, Fallah-Rad N, Lytwyn M, Han SY et al. Relation of biomarkers and cardiac magnetic resonance imaging after marathon running. Am J Cardiol 2009;103:1467-72.
140. Trivax JE, Franklin BA, Goldstein JA, Chinnaiyan KM, Gallagher MJ, de Jong AT et al. Acute cardiac effects of marathon running. J Appl Physiol 2010;108:1148-53.
141. Shave R, George K, Whyte G, Hart E, Middleton N. Post exercise changes in left ventricular function: the evidence so far. Med Sci Sports Exerc 2008;40:1393-9.
142. Neilan TG, Januzzi JL, Lee-Lewandrowski E, Ton-Nu TT, Yoerger DM, Jassal DS et al. Myocardial injury and ventricular dysfunction related to training levels among non elite participants in the Boston marathon. Circulation 2006;114: 2325-33.
143. Neilan TG, Yoerger DM, Douglas PS, Ton-Nu TT, Yoerger DM, Jassal DS et al. Persistent and reversible cardiac dysfunction among amateur marathon runners. Eur Heart J 2006;27:1079-84.
144. Cotrim C, Almeida AR, Miranda R, Almeida AG, Cotrim H, Picano E et al. Stress-induced intraventricular gradients in symptomatic athletes during upright exercise continuous wave Doppler echocardiography. Am J Cardiol 2010;106: 808-1812.
145. Nottin S, Doucende G, Schuster I, Tanguy S, Dauzat M, Obert P. Alteration in left ventricular strains and torsional mechanics after ultralong duration exercise in athletes. Circ Cardiovasc Imaging 2009;2:323-30.
146. Douglas PS, O'Toole ML, Hiller WD, Reichek N. Different effects of prolonged exercise on the right and left ventricles. J Am Coll Cardiol 1990;15:64-9.
147. La Gerche A, Connelly KA, Mooney DJ, MacIsaac AI, Prior DL. Biochemical and functional abnormalities of left and right ventricular function after ultra-endurance exercise. Heart 2008;94:860-6.
148. Kallioski KK, Laaksonen MS, Luotolahti M, Laine H, Takala TO, Nuutila P et al. Myocardial perfusion after marathon running. Scand J Med Sci Sports 2004;14: 208-14.
149. La Gerche A, Burns AT, Mooney DJ, Inder WJ, Taylor AJ, Bogaert J et al. Exercise-induced right ventricular dysfunction and structural remodelling in endurance athletes. Eur Heart J 2012;33:998-1006.
150. D'Andrea A, Caso P, Sarubbi B, Limongelli G, Liccardo B, Cice G et al. Right ventricular myocardial adaptation to different training protocols in top-level athletes. Echocardiography 2003;20:329-36.
151. La Gerche A, Heidbüchel H, Burns AT, Mooney DJ, Taylor AJ, Pfluger HB et al. Disproportionate exercise load and remodeling of the athletés right ventricle. Med Sci Sports Exerc 2011;43:974-81.
152. D'Andrea A, Caso P, Bossone E, Scarafile R, Riegler L, Di Salvo G et al. Right ventricular myocardial involvement in either physiological or pathological left ventricular hypertrophy: an ultrasound speckle- tracking two-dimensional strain analysis. Eur J Echocardiogr 2010;11:492-500.
153. Oxborough D, Shave R, Warburton D, Williams K, Oxborough A, Charlesworth S. Dilatation and dysfunction of the right ventricle immediately after ultra-endurance exercise: exploratory insights from conventional two-dimensional and speckle tracking echocardiography. Circ Cardiovasc Imaging 2011;4:253-63.
154. La Gerche A, Burns AT, D'Hooge J, Macisaac AI, Heidbüchel H, Prior DL. Exercise strain rate imaging demonstrates normal right ventricular contractile reserve and clarifies ambiguous resting measures in endurance athletes. J Am Soc Echocardiogr 2012;25:53-262.
155. D'Andrea A, Naeije R, D'Alto M, Argiento P, Golia E, Cocchia R et al. Range in pulmonary artery systolic pressure among highly trained athletes. Chest 2011;139: 788-94.
156. Bossone E, Rubenfire M, Bach DS, Ricciardi M, Armstrong WF. Range of tricuspid regurgitation velocity at rest and during exercise in normal adult men: implications for the diagnosis of pulmonary hypertension. J Am Coll Cardiol 1999; 33:1662-6.
157. Chandra N, Bastiaenen R, Papadakis M, Sharma S. Sudden cardiac death in young athletes: practical challenges and diagnostic dilemma. J Am Coll Cardiol 2013;61: 1027-40.
158. Chandra N, Papadakis M, Sharma S. Pre-participation screening of young competitive athletes for cardiovascular disorders. Phys Sports Med 2010;38:54-63.
159. Ljungqvist A, Jenoure PJ, Engebretsen L, Alonso JM, Bahr R, Clough AF et al. The International Olympic Committee (IOC) consensus statement on periodic atlhete evaluation of elite athletes, March 2009. Clin J Sport Med 2009;19:347-65.
160. Montgomery JV, Harris KM, Casey SA, Zenovich AG, Maron BJ. Relation of electrocardiographic patterns to phenotypic expression and clinical outcome in hypertrophic cardiomyopathy. Am J Cardiol 2005;96:270-5.
161. Marcus FI. Electrocardiographic features of inherited diseases that predispose to the development of cardiac arrhythmias, long QT syndrome, arrhythmogenic right ventricular cardiomyopathy/dysplasia, and Brugada syndrome. J Electrocardiol 2000;33:S1-S10.
162. Corrado D, Basso C, Pavei A, Michieli P, Schiavon M, Thiene G. Trends in sudden cardiovascular death in young competitive athletes after implementation of a preparticipation screening program. JAMA 2006;296:1593-601.
163. Steinvil A, Chundadze T, Zeltser D, Rogowki O, Halkin A, Galily Y et al. Mandatory electrocardiographic screening of athletes to reduce their risk for sudden death. J Am Coll Cardiol 2011;57:1291-6.
164. La Gerche A, Baggish AL, Knuuti J, Prior DL, Sharma S, Heidbuchel H et al. Cardiac imaging and stress testing in asymptomatic athletes to identify those at risk of sudden cardiac death. JACC Cardiovasc Imaging 2013;6:993-1007.
165. La Gerche A, Taylor AJ, Prior DL. Athletés Heart: the potential for multimodality imaging to address the critical remaining questions. J Am Coll Cardiol Img 2009;2: 350-63.
166. Basavarajaiah S, Wilson M, Whyte G, Shah A, McKennaW, Sharma S. Prevalence of hypertrophic cardiomyopathy in highly trained athletes: relevance to preparticipation screening. J Am Coll Cardiol 2008;51:1033-9.
167. Whyte GP, George K, Sharma S, Firoozi S, Stephens N, Senior R et al. The upper limit of physiological cardiac hypertrophy in elite male and female athletes: the British experience. Eur J Appl Physiol 2004;92:592-7.
168. Pelliccia A, Maron BJ, Culasso F, Spataro A, Caselli G. Athletés heart in women. Echocardiographic characterization of highly trained elite female athletes. JAMA 1996;276:211-2155.
169. Rawlins J, Carre F, Kervio G, Papadakis M, Chandra N, EdwardsC et al. Ethnic differences in physiological cardiac adaptation to intense physical exercise in highly trained female athletes. Circulation 2010;121:1078-85.
170. Makan J, Sharma S, Firoozi S, Whyte G, Jackson PG, McKenna WJ. Physiological upper limits of ventricular cavity size in highly trained adolescent athletes. Heart 2005;91:495-9.
171. Pelliccia A, Di Paolo FM, DeBlasiis E, Quattrini FM, Pisicchio C, Guerra E et al. Prevalence and clinical significance of aortic root dilation in highly trained competitive athletes. Circulation 2010;122:698-706.
172. D'Andrea A, Cocchia R, Riegler L, Scarafile R, SalernoG, GravinoR et al. Aortic root dimensions in elite athletes. Am J Cardiol 2010;105:1629-34.
173. Zaidi A, Ghani S, Sharma R, Oxborough D, Panoulas VF, SheikhN et al. Physiological right ventricular adaptation in elite athletes of African and Afro-Caribbean origin. Circulation 2013;127:1783-92.
174. Montalescot G, Sechtem U, Achenbach S, Andreotti F, Arden C, BudaiA et al. 2013 ESC guidelines on the management of stable coronary artery disease. Eur Heart J 2013;34:2949-3003.
175. Sicari R, Galderisi M, Voigt JU, Habib G, Zamorano JL, Lancellotti P et al. The use of pocket size imaging devices: a position statement of the European association of Echocardiography. Eur J Echocardiogr 2011;12:85-7.